Page last updated: 2024-08-22

monoethylglycinexylidide and erythromycin

monoethylglycinexylidide has been researched along with erythromycin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cakaloglu, Y; Devlin, J; Tredger, JM; Williams, R1
Watkins, PB1
Isohanni, MH; Neuvonen, PJ; Olkkola, KT2
Backman, JT; Kivistö, KT; Neuvonen, PJ; Taavitsainen, P; Wang, JS; Wen, X1
Danhof, M; Groeneveld, AB; Swart, EL; Touw, DJ; van der Hoven, B1

Reviews

1 review(s) available for monoethylglycinexylidide and erythromycin

ArticleYear
Noninvasive tests of CYP3A enzymes.
    Pharmacogenetics, 1994, Volume: 4, Issue:4

    Topics: Animals; Breath Tests; Cytochrome P-450 Enzyme System; Dapsone; Erythromycin; Humans; Hydrocortisone; Lidocaine; Liver; Midazolam; Nifedipine

1994

Trials

2 trial(s) available for monoethylglycinexylidide and erythromycin

ArticleYear
Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaine.
    Pharmacology & toxicology, 1999, Volume: 84, Issue:3

    Topics: Administration, Oral; Adult; Anesthetics, Local; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Drug Interactions; Erythromycin; Female; Humans; Itraconazole; Lidocaine; Male; Mixed Function Oxygenases; Placebos; Protein Synthesis Inhibitors

1999
Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine.
    Basic & clinical pharmacology & toxicology, 2006, Volume: 99, Issue:2

    Topics: Administration, Oral; Adult; Anesthetics, Local; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Erythromycin; Female; Fluvoxamine; Half-Life; Humans; Lidocaine; Male; Metabolic Clearance Rate; Nausea

2006

Other Studies

3 other study(ies) available for monoethylglycinexylidide and erythromycin

ArticleYear
Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients.
    Hepatology (Baltimore, Md.), 1994, Volume: 20, Issue:2

    Topics: Aryl Hydrocarbon Hydroxylases; Breath Tests; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Erythromycin; Female; Humans; Lidocaine; Liver Transplantation; Male; Oxidoreductases, N-Demethylating; Predictive Value of Tests; Regression Analysis; Tacrolimus

1994
Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro.
    Pharmacology & toxicology, 1999, Volume: 85, Issue:5

    Topics: Anesthetics, Local; Autopsy; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythromycin; Fluvoxamine; Humans; In Vitro Techniques; Ketoconazole; Lidocaine; Male; Microsomes, Liver; Middle Aged; Mixed Function Oxygenases

1999
Correlation between midazolam and lignocaine pharmacokinetics and MEGX formation in healthy volunteers.
    British journal of clinical pharmacology, 2002, Volume: 53, Issue:2

    Topics: Adult; Drug Interactions; Erythromycin; Female; Humans; Hypnotics and Sedatives; Lidocaine; Liver Function Tests; Male; Midazolam; Time Factors

2002